Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Cancer Research and Clinical Oncology|August 6, 2009
Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PKMelanie Schmidt, Hans-Ullrich Voelker, Michaela Kapp, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|February 4, 2016
CD33(+) /HLA-DR(neg) and CD33(+) /HLA-DR(+/-) Cells: Rare Populations in the Human Decidua with Characteristics of MDSCCatharina Bartmann, Markus Junker, Sabine E Segerer, et al.Anticancer Research|December 11, 2012
Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosisMathias Krockenberger, Peter Kranke, Sebastian Häusler, et al.Oncology Reports|July 7, 2009
Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibitionJörg B Engel, Tanja Schönhals, Claudia Weidler, et al.Anticancer Research|July 2, 2010
The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancerCarina Benesch, Christine Schneider, Hans-Ullrich Voelker, et al.Journal of Cancer Research and Clinical Oncology|November 17, 2009
Macrophage migration inhibitory factor expression in cervical cancerMathias Krockenberger, Jörg B Engel, Julia Kolb, et al.Archives of Gynecology and Obstetrics|April 21, 2010
Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancersJörg B Engel, Tanja Schönhals, Sebastian Häusler, et al.Oncology|March 24, 2017
Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?Tanja Stüber, Igor Novopashenny, Joachim Diessner, et al.Breast (Edinburgh, Scotland)|November 7, 2016
Factors influencing the development of visceral metastasis of breast cancer: A retrospective multi-center studyCatharina Bartmann, Joachim Diessner, Maria Blettner, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 9, 2008
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylationJörg B Engel, Arnd Honig, Tanja Schönhals, et al.Pageof 3